Medtronic (NYSE:MDT) and IBM Watson Health today launched a new feature for its Sugar.IQ personal diabetes assistant app that can predict the likelihood of a user experiencing a low glucose event within a four-hour window. The feature, called IQcast, uses AI tech from IBM and becomes more accurate as the low blood sugar event draws nearer, […]
IBM Watson Health
Medtronic, IBM Watson Health launch AI-powered diabetes management app
Medtronic (NYSE:MDT), in partnership with IBM Watson Health, this week announced commercial availability of its AI-powered Sugar.IQ diabetes management app. Using artificial intelligence, the Sugar.IQ app evaluates how a user’s blood sugar levels respond to variables such as food intake, insulin dosing and other daily routines. At this year’s meeting of the American Diabetes Association, Medtronic […]
Novartis, IBM Watson collab to optimize care for patients with advanced breast cancer
Novartis (NYSE:NVS) said today that it inked a deal with IBM Watson Health to optimize care and improve outcomes for patients with advanced breast cancer. The 2 companies plan to develop a “cognitive solution” using real-world patient data and analytics to better understand expected outcomes of breast cancer treatment options and develop personalized treatment plans […]
Study: Growing concern over narcotic painkillers and their addiction risk
More than 50% of Americans have been prescribed narcotic painkillers, according to a Truven Health Analytics-NPR Health poll, and more than one third of respondents were concerned about painkillers’ addiction risk, effectiveness and side effects. The concern towards prescription painkillers differed between those who have been prescribed narcotic pain-relievers and those who have not. Just over […]
Broad Institute, IBM Watson launch initiative to study cancer drug resistance
IBM Watson Health (NYSE:IBM) and the Broad Institute said today that they’ve launched a research initiative with the hopes of discovering the basis for cancer drug resistance. The 5 year, $50 million collaboration will utilize the genetic information of thousands of drug resistant tumors and Watson’s machine learning methods to help understand the underlying mechanisms […]
